Pfizer vaccine

As more people become eligible for Pfizer’s COVID-19 booster shot, are there any side effects or risks associated with the next vaccine dose?

With more than 40 million doses of coronavirus vaccines available, U.S. health authorities said they’re confident there will be enough for every American who qualifies

As more people become eligible for Pfizer’s COVID-19 booster shot, are there any side effects or risks associated with the next vaccine dose?

Federal experts have indicated the Pfizer shots would not be recommended for people who got a different brand of vaccine initially.

Pharmaceutical giant BioNTech, which worked with Pfizer to create their mRNA coronavirus vaccine, told German news weekly Der Spiegel in an interview published Friday that it would be seeking FDA approval “over the next few weeks” for use of its vaccine in children ages 5 to 11.

Preliminary data from the Israeli Health Ministry suggests that senior citizens who received a Pfizer vaccine booster had five to six times more protection against serious illness and hospitalization after 10 days.

The U.S. gave full approval to Pfizer’s COVID-19 vaccine Monday, potentially boosting public confidence in the shots and instantly opening the way for more universities, companies and local governments to make vaccinations mandatory. NBC 5’s Chris Hush reports.

Now that the FDA has given the Pfizer-BioNTech COVID-19 vaccine its stamp of full approval, doctors hope that some vaccine skeptics will finally be convinced to get the shot. As NBC News medical contributor Dr. Kavita Patel explains, the approval is also likely to lead to more vaccine mandates by employers.

The FDA gave Pfizer-BioNTech’s two-dose coronavirus vaccine full approval on Monday for all Americans over the age of 16. The vaccine, which will now be marketed as Comirnaty, is the first COVID-19 vaccine to receive full approval by the agency.

A preliminary survey out of Israel suggests that a coronavirus booster shot may cause similar side effects to the second dose.

The U.S. government’s top infectious disease expert, Dr. Anthony Fauci, says he’s hopeful that the Food and Drug Administration will give full approval to the coronavirus vaccine by month’s end.

So far, the “variant of interest” has been detected in 29 countries, and it may spread more quickly than milder versions of the coronavirus.

9-year-old Daemo Gregorie-Cradick is one of the 250 kids ages 5 to 11 who are participating in a trial of the Pfizer coronavirus vaccine at the Children’s Hospital Colorado. If the trial is successful, experts say vaccines for kids under 12 could be just months away.

A new study from the University of Miami found that the Pfizer and Moderna coronavirus vaccines– the two mRNA vaccines that currently have emergency use authorization in the U.S.– do not contribute to male infertility.

The U.S. will buy 500 million more doses of the Pfizer COVID-19 vaccine to share through the COVAX alliance for donation to 92 lower income countries and the African Union over the next year.

The Centers for Disease Control and Prevention says it is investigating after a small number of teens and young adults reported having heart problems after being vaccinated for COVID-19.

Families are preparing after the FDA issued an emergency use authorization for the Pfizer vaccine for children 12 and older. NBC 5’s Alex Maragos has the story.

The FDA has given an emergency use authorization for the Pfizer vaccine, allowing teens aged 12-to-15 to be given the vaccine. NBC 5’s Chris Coffey has reaction from parents on the decision.